PERKINELMER INC (PKI) Fundamental Analysis & Valuation

NYSE:PKI • US7140461093

Current stock price

115.24 USD
-1.06 (-0.91%)
At close:
115.24 USD
0 (0%)
After Hours:

This PKI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PKI Profitability Analysis

1.1 Basic Checks

  • In the past year PKI was profitable.
  • In the past year PKI had a positive cash flow from operations.
PKI Yearly Net Income VS EBIT VS OCF VS FCFPKI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 500M 1B

1.2 Ratios

  • PKI's Return On Assets of 5.28% is fine compared to the rest of the industry. PKI outperforms 76.19% of its industry peers.
  • PKI's Return On Equity of 10.11% is fine compared to the rest of the industry. PKI outperforms 77.78% of its industry peers.
  • With a decent Return On Invested Capital value of 6.49%, PKI is doing good in the industry, outperforming 73.02% of the companies in the same industry.
  • PKI had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 11.80%.
  • The 3 year average ROIC (52.37%) for PKI is well above the current ROIC(6.49%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROIC 6.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
PKI Yearly ROA, ROE, ROICPKI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 5 10 15

1.3 Margins

  • PKI has a Profit Margin of 16.32%. This is amongst the best in the industry. PKI outperforms 82.54% of its industry peers.
  • In the last couple of years the Profit Margin of PKI has grown nicely.
  • Looking at the Operating Margin, with a value of 23.43%, PKI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PKI has grown nicely.
  • PKI has a Gross Margin of 58.39%. This is in the better half of the industry: PKI outperforms 76.19% of its industry peers.
  • In the last couple of years the Gross Margin of PKI has grown nicely.
Industry RankSector Rank
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
PKI Yearly Profit, Operating, Gross MarginsPKI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PKI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PKI is creating value.
  • The number of shares outstanding for PKI remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, PKI has an improved debt to assets ratio.
PKI Yearly Shares OutstandingPKI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
PKI Yearly Total Debt VS Total AssetsPKI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PKI has a Altman-Z score (2.51) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of PKI is 7.40, which is on the high side as it means it would take PKI, 7.40 years of fcf income to pay off all of its debts.
  • PKI's Debt to FCF ratio of 7.40 is fine compared to the rest of the industry. PKI outperforms 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that PKI is somewhat dependend on debt financing.
  • PKI has a worse Debt to Equity ratio (0.53) than 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Altman-Z 2.51
ROIC/WACC0.65
WACC10.02%
PKI Yearly LT Debt VS Equity VS FCFPKI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.3 Liquidity

  • PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
  • PKI has a Current ratio of 2.13. This is in the lower half of the industry: PKI underperforms 68.25% of its industry peers.
  • PKI has a Quick Ratio of 1.87. This is a normal value and indicates that PKI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.87, PKI is doing worse than 65.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.87
PKI Yearly Current Assets VS Current LiabilitesPKI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. PKI Growth Analysis

3.1 Past

  • PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
  • The Earnings Per Share has been growing by 22.15% on average over the past years. This is a very strong growth
  • Looking at the last year, PKI shows a decrease in Revenue. The Revenue has decreased by -3.37% in the last year.
  • PKI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%

3.2 Future

  • Based on estimates for the next years, PKI will show a small growth in Earnings Per Share. The EPS will grow by 6.04% on average per year.
  • Based on estimates for the next years, PKI will show a decrease in Revenue. The Revenue will decrease by -8.60% on average per year.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PKI Yearly Revenue VS EstimatesPKI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PKI Yearly EPS VS EstimatesPKI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. PKI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.51, PKI is valued correctly.
  • 96.83% of the companies in the same industry are more expensive than PKI, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.51. PKI is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PKI indicates a somewhat cheap valuation: PKI is cheaper than 77.78% of the companies listed in the same industry.
  • PKI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
PKI Price Earnings VS Forward Price EarningsPKI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PKI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PKI is cheaper than 93.65% of the companies in the same industry.
  • PKI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PKI is cheaper than 87.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.52
EV/EBITDA 12.35
PKI Per share dataPKI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • PKI has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as PKI's earnings are expected to decrease with -4.57% in the coming years.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PKI Dividend Analysis

5.1 Amount

  • PKI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PKI Fundamentals: All Metrics, Ratios and Statistics

PERKINELMER INC

NYSE:PKI (5/15/2023, 8:04:00 PM)

After market: 115.24 0 (0%)

115.24

-1.06 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-11
Earnings (Next)07-31
Inst Owners86.56%
Inst Owner Change-6.71%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
P/S 3.19
P/FCF 24.52
P/OCF 21.43
P/B 1.97
P/tB N/A
EV/EBITDA 12.35
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROCE N/A
ROIC 6.49%
ROICexc 6.74%
ROICexgc 35.96%
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Debt/EBITDA 2.93
Cap/Depr 20.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 79.63%
Current Ratio 2.13
Quick Ratio 1.87
Altman-Z 2.51
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%

PERKINELMER INC / PKI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PKI.


What is the valuation status of PERKINELMER INC (PKI) stock?

ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.


What is the profitability of PKI stock?

PERKINELMER INC (PKI) has a profitability rating of 3 / 10.


What is the financial health of PERKINELMER INC (PKI) stock?

The financial health rating of PERKINELMER INC (PKI) is 4 / 10.


What is the earnings growth outlook for PERKINELMER INC?

The Earnings per Share (EPS) of PERKINELMER INC (PKI) is expected to decline by -34.36% in the next year.